Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-879P is a processed, non-coding RNA pseudogene derived from the U6 small nuclear RNA (snRNA) gene, which is a crucial component of spliceosomal snRNP complexes responsible for mRNA splicing in eukaryotes. Unlike the functional U6 snRNA, the RNU6-879P copy is a retrotransposed, non-functional sequence created through L1-dependent retrotransposition, and does not encode a functional RNA or protein product. The human genome contains many such snRNA pseudogenes, but their presence mainly reflects genome evolution and retrotransposon activity, not direct biological function. There is no evidence that RNU6-879P—or any specific U6 snRNA pseudogene—serves as a therapeutic target, disease biomarker, or participates in canonical cellular processes. Key Points: RNU6-879P is a non-coding RNA pseudogene, not a drug target, receptor, or enzyme. It is not considered therapeutically actionable; does not fulfill criteria for a classical molecular target. Its main significance lies in retrotransposition and genomic architecture, not in biological function or disease causality.
None applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 879, pseudogene (RNU6-879P).